Predictors of hemoglobin decline in non-metastatic prostate cancer patients on androgen deprivation therapy: a matched cohort study

被引：0
|
作者：
Narhari Timilshina
Shabbir Hussain
Henriette Breunis
Shabbir M. H. Alibhai
机构：
[1] University Health Network,Division of General Internal Medicine & Clinical Epidemiology
[2] Toronto Rehabilitation Institute,Geriatric Program
[3] University of Toronto,Department of Medicine
[4] University of Toronto,Department of Health Policy, Management and Evaluation
来源：
Supportive Care in Cancer | 2011年 / 19卷
关键词：
Anemia; Prostate cancer; Androgen deprivation therapy; Aged;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1815 / 1821
页数：6
相关论文
共 50 条
  • [31] Changes in blood glucose and cholesterol levels due to androgen deprivation therapy in men with non-metastatic prostate cancer
    Mohamedali, Hassanabbas Z.
    Breunis, Henriette
    Timilshina, Narhari
    Alibhai, Shabbir M. H.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2011, 5 (01): : 28 - 32
  • [32] Predictors of clinical metastases in prostate cancer patients on androgen deprivation therapy
    Abouassaly, Robert
    Paciorek, Alan
    Klein, Eric A.
    Ryan, Charles J.
    Carroll, Peter R.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 148 - 149
  • [33] SEX LIFE IN PATIENTS WITH METASTATIC PROSTATE CANCER ON ANDROGEN DEPRIVATION THERAPY
    Ermec, Bahadir
    Taskapu, Hakan Hakki
    Dincer, Murat
    Ortac, Mazhar
    Salabas, Emre
    Kadioglu, Ates
    NOBEL MEDICUS, 2015, 11 (02): : 5 - 12
  • [34] PREDICTORS OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS ON ANDROGEN DEPRIVATION THERAPY FOR METASTATIC PROSTATE CANCER
    Schubbe, Morgan
    Tobert, Conrad
    Bell, Sarah
    Garje, Rohan
    Erickson, Bradley
    Gellhaus, Paul
    JOURNAL OF UROLOGY, 2020, 203 : E1221 - E1221
  • [35] The impact of androgen-deprivation therapy (ADT) on the risk of cardiovascular (CV) events in patients with non-metastatic prostate cancer: a population-based study
    Gandaglia, Giorgio
    Sun, Maxine
    Popa, Ioana
    Schiffmann, Jonas
    Abdollah, Firas
    Quoc-Dien Trinh
    Saad, Fred
    Graefen, Markus
    Briganti, Alberto
    Montorsi, Francesco
    Karakiewicz, Pierre I.
    BJU INTERNATIONAL, 2014, 114 (6B) : E82 - E89
  • [36] 11-Ketotestosterone and time to castration resistance in patients with recurrent non-metastatic prostate cancer receiving androgen deprivation therapy.
    Guillemette, Chantal
    Dahmani, Cylia
    Caron, Patrick
    Simonyan, David
    Lacombe, Louis
    Aprikian, Armen G.
    Saad, Fred
    Carmel, Michel
    Chevalier, Simone
    Levesque, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 209 - 209
  • [37] Impact of androgen deprivation therapy (ADT) on quality of life (QL), cognitive and physical function of patients with non-metastatic prostate cancer (PC)
    Joly, F
    Alibhai, S
    Galica, J
    Soban, F
    Park, A
    Yi, QL
    Wagner, L
    Tannock, I
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 409S - 409S
  • [38] The role of androgen deprivation therapy in prostate cancer patients with non-metastatic disease recurrence after local curative treatment: a systematic review
    van den Bergh, Roderick
    BJU INTERNATIONAL, 2015, 116 : 5 - 6
  • [39] ANDROGEN DEPRIVATION THERAPY FOR NON-METASTATIC PROSTATE CANCER IS ASSOCIATED WITH AN INCREASED RISK OF PERIPHERAL ARTERIAL DISEASE AND VENOUS THROMBOEMBOLISM
    Hu, Jim
    Williams, Stephen
    O'Malley, A.
    Smith, Matthew
    Paul Nguyen
    Keating, Nancy
    JOURNAL OF UROLOGY, 2012, 187 (04): : E71 - E71
  • [40] THE EFFECT OF ANDROGEN DEPRIVATION THERAPY ON INSOMNIA SYMPTOMS, FATIGUE, MOOD, AND HOT FLASHES IN MEN WITH NON-METASTATIC PROSTATE CANCER
    Van Wijk, Megan
    Garland, Sheila N.
    Wall, Kayla
    Sathya, Jinka
    Thoms, John
    SLEEP, 2019, 42
12345